These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34715013)

  • 21. Polyamines in Parkinson's Disease: Balancing Between Neurotoxicity and Neuroprotection.
    Vrijsen S; Houdou M; Cascalho A; Eggermont J; Vangheluwe P
    Annu Rev Biochem; 2023 Jun; 92():435-464. PubMed ID: 37018845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CHO cells expressing the human P₅-ATPase ATP13A2 are more sensitive to the toxic effects of herbicide paraquat.
    Pinto Fde T; Corradi GR; Hera DP; Adamo HP
    Neurochem Int; 2012 Feb; 60(3):243-8. PubMed ID: 22265822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P5B-ATPases in the mammalian polyamine transport system and their role in disease.
    Azfar M; van Veen S; Houdou M; Hamouda NN; Eggermont J; Vangheluwe P
    Biochim Biophys Acta Mol Cell Res; 2022 Dec; 1869(12):119354. PubMed ID: 36064065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural Basis of Substrate-Independent Phosphorylation in a P4-ATPase Lipid Flippase.
    Timcenko M; Dieudonné T; Montigny C; Boesen T; Lyons JA; Lenoir G; Nissen P
    J Mol Biol; 2021 Aug; 433(16):167062. PubMed ID: 34023399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Common pathogenic effects of missense mutations in the P-type ATPase ATP13A2 (PARK9) associated with early-onset parkinsonism.
    Podhajska A; Musso A; Trancikova A; Stafa K; Moser R; Sonnay S; Glauser L; Moore DJ
    PLoS One; 2012; 7(6):e39942. PubMed ID: 22768177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity.
    Ramonet D; Podhajska A; Stafa K; Sonnay S; Trancikova A; Tsika E; Pletnikova O; Troncoso JC; Glauser L; Moore DJ
    Hum Mol Genet; 2012 Apr; 21(8):1725-43. PubMed ID: 22186024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes.
    Kong SM; Chan BK; Park JS; Hill KJ; Aitken JB; Cottle L; Farghaian H; Cole AR; Lay PA; Sue CM; Cooper AA
    Hum Mol Genet; 2014 Jun; 23(11):2816-33. PubMed ID: 24603074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parkinson's disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction.
    Park JS; Koentjoro B; Veivers D; Mackay-Sim A; Sue CM
    Hum Mol Genet; 2014 Jun; 23(11):2802-15. PubMed ID: 24399444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9).
    Daniel G; Musso A; Tsika E; Fiser A; Glauser L; Pletnikova O; Schneider BL; Moore DJ
    Neurobiol Dis; 2015 Jan; 73():229-43. PubMed ID: 25461191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for modulators of spermine tolerance identifies Sky1, the SR protein kinase of Saccharomyces cerevisiae, as a regulator of polyamine transport and ion homeostasis.
    Erez O; Kahana C
    Mol Cell Biol; 2001 Jan; 21(1):175-84. PubMed ID: 11113192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular function and pathological role of ATP13A2 and related P-type transport ATPases in Parkinson's disease and other neurological disorders.
    van Veen S; Sørensen DM; Holemans T; Holen HW; Palmgren MG; Vangheluwe P
    Front Mol Neurosci; 2014; 7():48. PubMed ID: 24904274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural Dynamics and Catalytic Mechanism of ATP13A2 (PARK9) from Simulations.
    Mateeva T; Klähn M; Rosta E
    J Phys Chem B; 2021 Nov; 125(43):11835-11847. PubMed ID: 34676749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms.
    Park JS; Blair NF; Sue CM
    Mov Disord; 2015 May; 30(6):770-9. PubMed ID: 25900096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The strategic function of the P5-ATPase ATP13A2 in toxic waste disposal.
    de Tezanos Pinto F; Adamo HP
    Neurochem Int; 2018 Jan; 112():108-113. PubMed ID: 29169913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78).
    Estrada-Cuzcano A; Martin S; Chamova T; Synofzik M; Timmann D; Holemans T; Andreeva A; Reichbauer J; De Rycke R; Chang DI; van Veen S; Samuel J; Schöls L; Pöppel T; Mollerup Sørensen D; Asselbergh B; Klein C; Zuchner S; Jordanova A; Vangheluwe P; Tournev I; Schüle R
    Brain; 2017 Feb; 140(2):287-305. PubMed ID: 28137957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ATP13A3 is a major component of the enigmatic mammalian polyamine transport system.
    Hamouda NN; Van den Haute C; Vanhoutte R; Sannerud R; Azfar M; Mayer R; Cortés Calabuig Á; Swinnen JV; Agostinis P; Baekelandt V; Annaert W; Impens F; Verhelst SHL; Eggermont J; Martin S; Vangheluwe P
    J Biol Chem; 2021; 296():100182. PubMed ID: 33310703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ATP13A2 modifies mitochondrial localization of overexpressed TOM20 to autolysosomal pathway.
    Hatori Y; Kanda Y; Nonaka S; Nakanishi H; Kitazawa T
    PLoS One; 2022; 17(11):e0276823. PubMed ID: 36445873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ATP13A2 facilitates HDAC6 recruitment to lysosome to promote autophagosome-lysosome fusion.
    Wang R; Tan J; Chen T; Han H; Tian R; Tan Y; Wu Y; Cui J; Chen F; Li J; Lv L; Guan X; Shang S; Lu J; Zhang Z
    J Cell Biol; 2019 Jan; 218(1):267-284. PubMed ID: 30538141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of the Parkinson's disease gene PARK9 in essential cellular pathways and the manganese homeostasis network in yeast.
    Chesi A; Kilaru A; Fang X; Cooper AA; Gitler AD
    PLoS One; 2012; 7(3):e34178. PubMed ID: 22457822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia regulation of ATP13A2 (PARK9) gene transcription.
    Xu Q; Guo H; Zhang X; Tang B; Cai F; Zhou W; Song W
    J Neurochem; 2012 Jul; 122(2):251-9. PubMed ID: 22288903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.